HEC CJ PHARM News

HEC CJ PHARM: 2023 Environmental, Social and Governance Report

Apr 26 10:55 ET

HEC CJ PHARM: Annual Report 2023

Apr 26 10:50 ET

HEC CJ PHARM: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO SHARING AGREEMENT AND REVISION OF PROPOSED ANNUAL CAP UNDER THE SHARING AGREEMENT

Apr 26 10:45 ET

HEC CJ PHARM: JOINT ANNOUNCEMENT MONTHLY UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE IN RELATION TO THE POSSIBLE MERGER OF THE COMPANY

Apr 8 05:34 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 05:09 ET

HEC CJ PHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

Mar 28 06:09 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 21 04:36 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 21 04:36 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 20 04:52 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 20 04:52 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 19 05:08 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 19 05:08 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 18 04:34 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 18 04:34 ET

HEC CJ PHARM: NOTICE OF BOARD MEETING

Mar 18 04:31 ET

HEC CJ PHARM: SUPPLEMENTAL ANNOUNCEMENT POSITIVE PROFIT ALERT

Mar 15 10:40 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 14 04:49 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 14 04:49 ET

HEC CJ PHARM: ANNOUNCEMENT POSITIVE PROFIT ALERT

Mar 12 10:39 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 12 05:30 ET